Baseline serum from 502 participants in the Prostate , Lung , Colorectal , and Ovarian ( PLCO ) Cancer Screening Trial was analyzed by using ultra-high-performance liquid-phase chromatography with tandem mass spectrometry and gas chromatography-mass spectrometry .